Arcutis Biotherapeutics, Inc. financial data

Symbol
ARQT on Nasdaq
Industry
Pharmaceutical Preparations
Location
3027 Townsgate Road, Suite 300, Westlake Village, California
State of incorporation
Delaware
Fiscal year end
December 31
Former names
Arcutis, Inc. (to 9/9/2019)
Latest financial report
Q1 2024 - May 14, 2024

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 805 % -29.7%
Quick Ratio 29.4 %
Debt-to-equity 225 % +123%
Return On Equity -197 % -22.9%
Return On Assets -60.7 % +24.1%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 96.8M shares +57.6%
Common Stock, Shares, Outstanding 116M shares +88.2%
Entity Public Float 487M USD -44.6%
Common Stock, Value, Issued 12K USD +100%
Weighted Average Number of Shares Outstanding, Basic 111M shares +81.5%
Weighted Average Number of Shares Outstanding, Diluted 111M shares +81.5%

Income Statement

Label TTM Value / Value Unit Change %
Revenues 49.6M USD +1682%
Research and Development Expense 98.4M USD -44.5%
General and Administrative Expense 122M USD +100%
Costs and Expenses 81.2M USD +2.71%
Operating Income (Loss) -196M USD +37.7%
Nonoperating Income (Expense) -14.6M USD -354%
Income Tax Expense (Benefit) 324K USD
Net Income (Loss) Attributable to Parent -217M USD +33.6%
Earnings Per Share, Basic -2.79 USD/shares +51.1%
Earnings Per Share, Diluted -2.79 USD/shares +51.1%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 190M USD +134%
Accounts Receivable, after Allowance for Credit Loss, Current 37.2M USD +191%
Inventory, Net 13.2M USD +54.9%
Assets, Current 468M USD +27.3%
Property, Plant and Equipment, Net 1.37M USD -33.9%
Operating Lease, Right-of-Use Asset 2.26M USD -14%
Intangible Assets, Net (Excluding Goodwill) 6.25M USD -10.7%
Other Assets, Noncurrent 596K USD +664%
Assets 479M USD +26.1%
Accounts Payable, Current 13M USD +3.88%
Employee-related Liabilities, Current 7.48M USD +24.8%
Accrued Liabilities, Current 33.6M USD +40.7%
Liabilities, Current 47.3M USD +27.8%
Operating Lease, Liability, Noncurrent 3.18M USD -19.2%
Other Liabilities, Noncurrent 306K USD
Liabilities 254M USD +5.79%
Accumulated Other Comprehensive Income (Loss), Net of Tax -133K USD +67.9%
Retained Earnings (Accumulated Deficit) -1.02B USD -27.2%
Stockholders' Equity Attributable to Parent 225M USD +61%
Liabilities and Equity 479M USD +26.1%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -31.6M USD +60.7%
Net Cash Provided by (Used in) Financing Activities 162M USD +161664%
Net Cash Provided by (Used in) Investing Activities -28.7M USD -127%
Common Stock, Shares Authorized 300M shares 0%
Common Stock, Shares, Issued 116M shares +88.2%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect 101M USD +269%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 191M USD +132%
Deferred Tax Assets, Valuation Allowance 216M USD +32.8%
Deferred Tax Assets, Gross 217M USD +32.5%
Operating Lease, Liability 4.12M USD -13.8%
Depreciation 766K USD +18.4%
Payments to Acquire Property, Plant, and Equipment 0 USD -100%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent -217M USD +33.5%
Lessee, Operating Lease, Liability, to be Paid 4.81M USD -16.7%
Property, Plant and Equipment, Gross 3.46M USD +14.1%
Operating Lease, Liability, Current 756K USD +11.8%
Lessee, Operating Lease, Liability, to be Paid, Year Two 1.02M USD +3.02%
Lessee, Operating Lease, Liability, to be Paid, Year One 994K USD +3.01%
Operating Lease, Weighted Average Discount Rate, Percent 0.07 pure 0%
Deferred Income Tax Expense (Benefit) 0 USD
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 695K USD -30.7%
Lessee, Operating Lease, Liability, to be Paid, Year Three 1.05M USD +2.93%
Deferred Tax Assets, Operating Loss Carryforwards 152M USD +44.3%
Preferred Stock, Shares Issued 0 shares
Deferred Federal Income Tax Expense (Benefit) 0 USD
Current Income Tax Expense (Benefit) 3.11M USD
Preferred Stock, Shares Authorized 10M shares 0%
Unrecognized Tax Benefits 41.4M USD -2.62%
Lessee, Operating Lease, Liability, to be Paid, Year Four 1.09M USD +3.13%
Operating Lease, Payments 965K USD +23.6%
Additional Paid in Capital 1.24B USD +32.2%
Preferred Stock, Shares Outstanding 0 shares
Current State and Local Tax Expense (Benefit) 0 USD
Current Federal Tax Expense (Benefit) 0 USD
Amortization of Intangible Assets 750K USD 0%
Share-based Payment Arrangement, Expense 39.4M USD +10.5%
Deferred State and Local Income Tax Expense (Benefit) 0 USD
Interest Expense 30.2M USD +44.6%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%